DUNSIRE DEBORAH received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/18/2026ACC: 0001193125-26-229222
Director
Since Jun 2019
+21.81K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
21.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.75K
Price / share
—
Trade value
—
% of position
25.2%
5/14/2026
30.82K→38.57K
Total
Net shares
+7.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | A · Award | +7.75K | — | — | 25.2% | 30.82K | 38.57K |
| Total | +7.75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.06K shares
Shares
+14.06K
Strike price
25.80
Held after
14.06K
Exercisable
—
5/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.06K shares | 5/14/2026 | A · Award | +14.06K | 25.80 | — | 14.06K |